Millennium Management’s Belite Bio BLTE Stock Holding History

Millennium Management’s Portfolio BLTE Stock Details BLTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$90.9M	Buy	570,088 +11,206	+2%	+$1.88M	0.04%	489
2025 Q4	$89.4M	Buy	558,882 +538,141	+2,595%	+$63.7M	0.04%	477
2025 Q3	$1.53M	Buy	+20,741	New	+$1.36M	﹤0.01%	4283
2022 Q3	–	Sell	-8,995	Closed	-$280K	–	7068
2022 Q2	$280K	Buy	+8,995	New	+$169K	﹤0.01%	5425

Other funds holding BLTE

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Millennium Management's BLTE Position: Q1 2026 in Review

Millennium Management increased its Belite Bio (BLTE) stake by 2% in Q1 2026, buying an estimated $1.88M and bringing the position to 570,088 shares worth $90.9M. The position accounts for 0.04% of the portfolio, ranked #489.

Millennium Management first reported a position in BLTE in Q2 2022 and has held it in 4 quarters since. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

Millennium Management held 570,088 shares of Belite Bio worth $90.9M as of Q1 2026.
Millennium Management bought 11,206 Belite Bio shares in Q1 2026, an estimated $1.88M.
Belite Bio made up 0.04% of Millennium Management's portfolio in Q1 2026, its #489 holding.
Millennium Management first reported a position in Belite Bio in Q2 2022 and has held it in 4 quarters since.
75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.